SCI Pharmtech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	60.63	582.38	942.06	166.83	332.23
Trading Asset Securities	14.17	110.37	89	97.55	360.4
Cash & Short-Term Investments	74.8	692.76	1,031	264.37	692.63
Cash Growth	-89.20%	-32.81%	290.00%	-61.83%	9.42%
Accounts Receivable	247.93	289.51	307.37	173.57	82.98
Other Receivables	1.17	-	0.15	31.1	265.59
Receivables	249.1	289.51	307.52	204.67	348.56
Inventory	728.3	620.9	529.53	513.43	294.18
Other Current Assets	38.23	57.22	85.13	59.93	61.93
Total Current Assets	1,090	1,660	1,953	1,042	1,397
Property, Plant & Equipment	5,137	4,803	3,912	3,194	2,100
Long-Term Investments	187.05	237.52	241.62	208.04	124.97
Other Intangible Assets	29.65	37.77	46.15	54.58	60.29
Long-Term Deferred Tax Assets	161.56	143.82	153.28	167.25	241.55
Other Long-Term Assets	281.26	318.06	384.69	294.11	265.64
Total Assets	6,887	7,201	6,691	4,961	4,190
Accounts Payable	60.95	58.44	44.25	48.64	33.78
Accrued Expenses	60.3	99.04	110.72	128.35	121.46
Short-Term Debt	318.6	0.1	175	112	-
Current Portion of Long-Term Debt	360.11	403.44	20	-	-
Current Portion of Leases	5.62	2.47	1.95	0.83	1.58
Current Income Taxes Payable	42.89	85.25	11.54	3.86	-
Current Unearned Revenue	36.11	94.92	38.37	31.77	41.76
Other Current Liabilities	151.79	270.73	168.07	444.86	549.35
Total Current Liabilities	1,036	1,014	569.89	770.32	747.94
Long-Term Debt	258.39	578.01	842.67	432.36	-
Long-Term Leases	44.46	6.37	2.86	0.2	0.57
Long-Term Unearned Revenue	-	-	-	4.11	-
Pension & Post-Retirement Benefits	7.6	11.96	21.54	19.53	16.95
Long-Term Deferred Tax Liabilities	104.52	104.45	146	103.81	103.81
Other Long-Term Liabilities	41.02	8.68	7.84	1	-
Total Liabilities	1,492	1,724	1,591	1,331	869.26
Common Stock	1,195	1,195	1,195	953.82	953.82
Additional Paid-In Capital	2,235	2,235	2,234	1,357	1,348
Retained Earnings	1,968	2,037	1,646	1,373	1,067
Comprehensive Income & Other	-3.44	10.07	25.46	-54.73	-48.93
Shareholders' Equity	5,394	5,477	5,100	3,629	3,321
Total Liabilities & Equity	6,887	7,201	6,691	4,961	4,190
Total Debt	987.18	990.39	1,042	545.38	2.16
Net Cash (Debt)	-912.39	-297.63	-11.42	-281.01	690.48
Net Cash Growth	-	-	-	-	9.52%
Net Cash Per Share	-7.62	-2.48	-0.10	-2.61	6.42
Filing Date Shares Outstanding	119.51	119.51	119.51	107.3	107.3
Total Common Shares Outstanding	119.51	119.51	119.51	107.3	107.3
Working Capital	54.05	646.01	1,383	272.08	649.37
Book Value Per Share	45.14	45.83	42.67	33.82	30.95
Tangible Book Value	5,365	5,439	5,054	3,575	3,260
Tangible Book Value Per Share	44.89	45.51	42.29	33.31	30.38
Land	687.88	687.88	687.88	687.88	825.68
Buildings	723.37	722.9	707	700.23	684.47
Machinery	2,510	2,467	1,786	1,185	577.08
Construction In Progress	2,452	1,965	1,565	1,323	633.3

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.